| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections
+ S3 G5 v/ c) | }3 Y Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes
) z h" G" `* g( R( C' A, B/ A. o. C( C Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
% v/ k8 w; G6 } Press Release |
| 20. 1 o9 v; N! w& {& D, ]
. ]" X0 s! G7 O: w
| | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers
1 i& J+ C9 z2 E Press Release |
| 19. | Kerydin
$ l9 c( [/ h- b0 I9 h 4 g; Z) Z, c$ { Q r( k
| tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
! |/ Y& \, v9 H (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL)
) d5 d3 p0 G" L( g$ r Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections
$ O3 W) R8 V- j5 u1 S0 C Press Release |
| 16. | Jublia! r) }( c% w7 }8 m; {
. k$ y V- {3 D6 n+ B7 R | efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection): E, f" Z6 l0 r% Q8 q) o0 n
No Press Release |
| 15. | Dalvance
4 u. X3 m* S. m9 d
$ W& e% Z* E9 T6 A2 u( Q, P | dalbavancin | 5/23/2014 | To treat adults with skin infections
0 i5 n* a* S0 F) j Press Release |
| 14. | Entyvio
- U7 h4 N! t/ @. S) \6 \ 1 t$ I* {1 V8 u! J8 c
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease+ F# b3 i/ f) _4 ~& e- q- f
Press Release |
| 13. | Zontivity, V1 x) b$ T) Q% V- p2 J! [/ x( M
# I! s7 V* o8 V0 q | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients
- l7 ~5 T/ o1 E Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)9 w6 }/ P% @3 c
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)$ D! |# U* I+ r% ^, s
Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma
& \8 c+ M% R& A* z% a. K0 Q Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
9 c$ \7 {. j7 N! p# B Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
: @& @7 z# V1 C; M8 j. a Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis( B, T) j w- u$ [/ j( m S5 u
Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency2 W3 |, t1 L" y, n: r4 {# y
Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)
7 s8 w% f5 x1 k q0 Z0 P8 c Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome), _6 P$ w, }' o, n' v c) W
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
, w# [: H& @0 [- M Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对